[TLX] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[TLX] Telix Pharmaceuticals Limited
Announcement Date
29-Jun-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- -4.60%
YoY- -76.48%
Quarter Report
TLX's Result
TLX's Financial Summary
View:
Show?
Quarter Result
31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 CAGR
Revenue 4,686 2,910 3,606 1,607 1,667 1,818 195 188.29%
PBT -61,993 -37,046 -35,157 -25,096 -25,690 -17,125 -10,524 80.50%
Tax -13,997 -4,532 -8,571 -6,795 -8,192 -6,756 1,884 -
NP -47,996 -32,514 -26,586 -18,301 -17,497 -10,370 -8,640 77.01%
Tax Rate - - - - - - - -
Total Cost 52,682 35,424 30,192 19,908 19,165 12,187 8,835 81.23%
Ratio Analysis
31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 CAGR
NP Margin -1,024.24 -1,117.32 -737.27 -1,138.83 -1,049.33 -570.54 -4,430.77 -38.60%
Per Share
31/12/21 30/06/21 31/12/20 30/06/20 31/12/19 30/06/19 31/12/18 CAGR
EPS -0.17 -0.12 -0.10 -0.07 -0.07 -0.05 -0.04 61.90%
EPS Diluted -0.17 -0.12 -0.10 -0.07 -0.07 -0.05 -0.04 61.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.